Focus Stocks
Amgen Is Close to its 50 Day Moving Average
Published on Friday, 31 August 2012 06:12 Written by TradersHuddle Wire
New York, August 31st (TradersHuddle.com) - Amgen Inc. (NASDAQ:AMGN) closed the trading day at $83.15, near its 50 day moving average that is set at $79.18. Amgen's price action is just above this important support level, providing a trading opportunity.
Amgen Inc. (NASDAQ:AMGN) develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The company concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.
The peaks and troughs algorithm shows calculated support at $75.70 and calculated resistance at $85.28. These levels should also be evaluated when planning trades, as they provide an insight into the latest price action.
Traders wanting to establish a position on Amgen should look for evidence of buying near the 50 day moving average, and open this position as close as possible to this important level. Also, they need to consider the latest range defined by the peaks and troughs algorithm for insights on other key levels that might impact an upside or downside move.
Related Articles
- Approaching Support: Amgen
- Is Amgen Close to Support?
- Amgen Is Close to its 200 Day Moving Average
- Amgen Broke Support
- Trading the Setup In Amgen
- Approaching Support: Amgen
- Amgen Is Close to the 50 Day Moving Average
- Trading the Setup In Amgen
- NASDAQ 100 Round Up - Flat: FSLR, CTRP, BIDU
- Reference Points for Amgen
Related Partner Headlines
- Cramer's Top Stock Picks: AMGN, HPY, but Avoid JCP - TheStreet.com
- Amgen Stock To Go Ex-dividend Tomorrow (AMGN) - TheStreet.com
- Amgen Inc (AMGN): Today's Featured Drugs Winner - TheStreet.com
- Amgen Inc Stock Buy Recommendation Reiterated (AMGN) - TheStreet.com
- Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial Did Not Meet Primary Endpoint - Benzinga
- Amgen Inc Stock Buy Recommendation Reiterated (AMGN) - TheStreet.com
- UPDATE: Oppenheimer Raises PT to $89 on Amgen - Benzinga
- UPDATE: Jefferies & Company Reiterates Buy Rating, Raises PT on Amgen - Benzinga
- Amgen's Third Quarter Earnings Report - Investopedia
- Analysts' Actions: CAT AMGN DNKN BTU COF - TheStreet.com
TradersHuddle Search
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Dow Today: Verizon Communications (VZ) Higher - TheStreet.com -
Separating the Bargains From the Busts - TheStreet.com -
Cramer Quick Take: The 60-Inch TV Will Be Key This Holiday - TheStreet.com -
Cramer Quick Take: Cisco Wins If Fiscal Cliff Is Resolved - TheStreet.com -
Gap Up and Sit - TheStreet.com -
Apple, Intel, MicroStrategy: Tech Winners & Losers - TheStreet.com -
Windows 8 PC Sales Disappointing: Report - TheStreet.com -
Cramer Quick Take: Buy Home Depot and Lowe's - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:15,290.32 Trade time:12:39PM EDT Value change:▼27.91 (-0.18%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,648.85 Trade time:12:39PM EDT Value change:▼2.96 (-0.18%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:3,474.44 Trade time:12:39PM EDT Value change:▼7.74 (-0.22%)In The Wires
-
Bushmills™ Irish Whiskey Is Toast Of World Leaders At G8 Summit In Northern Ireland -
AudioEye Hires Chief Development Officer to Accelerate the Completion of AudioEye Voice Technology Platform -
Harvest Natural Resources To Present At The Global Hunter Securities 100 Energy Conference -
DIY Network's Interactive Home Building Series "Blog Cabin" Returns Monday, July 29 At 9:30 p.m. ET/PT -
Joseph Adamo appointed General Manager of Transat Distribution Canada -
Yale-New Haven neurosurgeons verifying effective eye tumor drug delivery localization with iMRI in VISIUS® Surgical Theatre -
AT&T and NEC Introduce Ultra-Rugged Smartphone Designed for Hard Work, Real Life -
Media Advisory - WestJet Encore to unveil its first Bombardier Q400








